Annual report pursuant to Section 13 and 15(d)

NOTES PAYABLE (Details Narrative)

v3.20.4
NOTES PAYABLE (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Jul. 28, 2020
Nov. 30, 2020
Nov. 30, 2019
Dec. 31, 2020
Dec. 31, 2019
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Instrument, Unamortized Discount       $ 2,262,388  
Interest Expense, Debt       1,126,534 $ 0
Fair Value, Inputs, Level 3 [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Secured debt       18,029,005  
Lenders [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Debt Instrument, Unamortized Discount       2,262,000  
Insurance Policy [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Prepaid expenses       $ 1,010,000  
Loan Agreement [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Notes payable   $ 909,375 $ 963,514    
Monthly principal and interest payments   $ 103,112 $ 109,413    
Monthly loan payments term   nine-month period nine-month period    
Annual interest rate   4.89% 5.25%    
Loan Agreement [Member] | K2 HealthVentures LLC [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Annual interest rate 8.50%     8.50%  
Secured debt $ 50,000,000     $ 21,190,000  
Debt description The loan matures on August 1, 2024 and the Company is obligated to make interest only payments for the first 24 months and then interest and equal principal payments for the next 24 months. Interest accrues at a variable annual rate equal to the greater of (i) 8.5% and (ii) the rate of interest noted in The Wall Street Journal, Money Rates section, as the “Prime Rate” plus 5.25%, in each case, subject to a step-down of 25 basis points upon the funding of the second tranche.        
Debt maturity date Aug. 01, 2024        
Debt conversion amount       $ 5,000,000  
Debt conversion per share       $ 9.40  
Warrants to purchase shares of common stock, exercised 86,206        
Exercise price of warrants $ 6.96        
Proceeds from warrant $ 472,000        
Proceeds from prepayment and default features 546,000        
Debt issuance cost 1,244,000        
Final payment 1,190,000     $ 1,190,000  
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche One [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Secured debt 20,000,000        
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche Two [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Secured debt 20,000,000        
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche Three [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Secured debt $ 10,000,000        
Event of Default - Loan Agreement [Member] | K2 HealthVentures LLC [Member]          
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]          
Annual interest rate       5.00%